[Genetic engineering and trends in the research on new vaccines].
The elaboration of vaccines, initially purely empirical, can now be made on a more rational basis thanks to our progresses in understanding the immune system and to our ability in expressing or mimicking immunogenic but innocuous parts of pathogens. We describe some of the factors contributing to the impressive acceleration in the research for new vaccines including the impact of genetic engineering. This impact is important both for the search of relevant immunogens and for their presentation to the host. We develop, in particular, the example of oral vaccines with live bacteria.
Hofnung
M
M
Unité de Programmation Moléculaire et Toxicologie Génétique, CNRS U. A. 271-INSERM U163, Paris.
D000941:Antigens / Q000276:immunology; D001424:Bacterial Infections / Q000517:prevention & control; D000939:Epitopes / Q000276:immunology; D005818:Genetic Engineering / Q000639:trends*; D006511:Hepatitis B Antigens / Q000235:genetics / Q000276:immunology; D015394:Molecular Structure; D014611:Vaccination; D014612:Vaccines; D014614:Vaccines, Synthetic / Q000276:immunology
D000941:Antigens; D000939:Epitopes; D006511:Hepatitis B Antigens; D014612:Vaccines; D014614:Vaccines, Synthetic
Génie génétique et tendances dans la recherche de nouveaux vaccins.